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Abstract
Background: The cranial cruciate ligament rupture (CCLR) is the most commonly encountered orthopedic condition
in dogs. Among the various techniques to treat this condition, tibial tuberosity advancement (TTA) has been used to
obtain rapid recovery of the affected knee. The objective of this study was to evaluate the viability of the use of
mesenchymal stem cells (MSC) implanted in the osteotomy site obtained by TTA in nine dogs diagnosed with CCLR.
Methods: The MSC were isolated from the adipose tissue of the dogs and cultured for eight days, the animals were
divided into two groups. Animals from the treated group (GT) received cell transport medium containing about 1.5
millions MSC, and the animals from the control group (GC) received only the cell transport medium. The study was
performed in a double-blind manner using radiographs acquired on days 15, 30, 60 and 120 after the procedure.
Evaluations of the density of the trabecular bone were performed using image analysis software. The results were
subjected to descriptive statistical analysis, followed by the normality test, Chi-square test, Mann-Whitney test and
Tukey’s multiple comparison test for p≤ 0.05.
Results: After 30 days of the procedure, the animals of the GT presented an ossification mean 36.45% greater
(p ≤ 0.033) than the GC, and there were no statistical differences for the other periods.
Conclusions: Despite the total bone ossification within the expected period, there was no minimization of
the estimated recovery time with the application of MSC, and inflammatory factors should be considered for
reassessment of the therapeutic intervention time.
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Background
The main function of the cranial cruciate ligament is the
stabilization of the knee, where it prevents cranial displace-
ment of the tibia in relation to the femur, in addition to
aiding the rotational movements of the tibia (Calvo et al.
2014; Fossum 2015; Venzin et al. 2004). Cranial cruciate
ligament rupture (CCLR) is the orthopedic knee condition
most common in dogs (Calvo et al. 2014; Marino and
Loughin 2010). The causes that lead to CCLR are still not
completely defined (Vedrine et al. 2013), but a number of
presumed factors lead to a common pathway in the origin
of these lesions (Cook 2010). Although the lesions are pri-
marily traumatic, other degenerative factors have been
noted in the pathogenesis of this condition, such as age,
sex, and obesity (Venzin et al. 2004), as well as racial pre-
disposition, inflammatory and conformation alterations,
and immune-mediated mechanisms (Griffon 2010).
The extracapsular techniques usually applied for the
treatment of this condition are the fabelo-tibial suture,
osteotomy of the tibial plateau, and advancement of the
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tibial tuberosity (TTA). In addition, there are intracapsu-
lar techniques that most commonly use the autogenous
fascia lata as material. Synthetic materials have not been
widely used due to the possibility of distension, rupture,
or infection (Fossum 2015).
The TTA demonstrates excellent results due to lack of
alteration of the original geometry of the knee joint and
its promoting of the distribution of pressure in the cartil-
age (Hoffmann et al. 2006). In addition, this technique is a
simple surgical procedure with less potential to generate
adverse effects due to technical problems (Boudrieau
2009). The use of the TTA technique in combination with
the application of stem cells provides a new option for the
treatment of CCLR.
Bone formation and repair are performed by osteopro-
genitor cells derived from mesenchymal stem cells
(MSC) that act in the lesion area by signaling cytokines
that stimulate the replication and differentiation in ac-
tive osteoblasts. The osteoblasts deposit an extracellular
matrix mineralized with hydroxyapatite (Kraus and
KIRKER-HEAD 2006). In addition, MSC also maintain
viability and potential multi-lineage after cryopreserva-
tion, so MSC can be effectively isolated, expanded, pre-
served and implanted (Kraus and KIRKER-HEAD 2006).
Kang et al. (2012) found that MSCs from adipose tis-
sue have a higher proliferation potential than the other
types of MSCs and that their main advantages over other
types of MSCs include easy availability in substantial
quantities and that they can be collected without risk to
the donor (Schäffler and Büchler 2007).
The aim of this study was to analyze the feasibility of
using MSCs implanted at the osteotomy site obtained dur-
ing the TTA technique in dogs with a CCLR diagnosis
and to verify the clinical recovery of the dogs after the use
of the TTA technique and implantation of MSCs at the
osteotomy site. Our hypothesis is that the use of MSC will
accelerate the cicatricial process after TTA in dogs.
Methods
A total of 9 male and female dogs from 1 to 12 years
old, including Maltese, Cane Corso, Shar-Pei, Labrador,
Pitbull, and mixed breeds, were selected in the ortho-
pedic clinical routine of the veterinary hospital Dr.
Antônio Clemenceau. All dogs had some degree of clau-
dication and were diagnosed with CCLR through clinical
examination, drawer test, and tibial compression, as well
as radiographic analysis in specific positioning for TTA
according to Hoffmann et al. (2006). The selected ani-
mals had complete and unilateral CCLR of the knee
joint, with three (33%) showing symptoms in the right
knee and six (67%) in the left knee. Five (55%) used cage
number 6 mm, three (33%) used the cage number
9 mm, and only one (11%) used the cage number
12 mm. The plates were chosen according to the
radiographic pattern with the animals properly posi-
tioned (femoro-tibial-patellar joint with 135° angulation)
and two plates at number 0, one plate at number 0.5,
two plates at number 1, plate number 2, two plates at
number 3 and a plate at number 4.
Surgery procedures
Lateral radiographic projection of the affected limb was
obtained pre-operatively to assess the stifle joint. The
lateral projection was centered on the stifle joint with
superimposition of both femoral condyles. The stifle
joint was angled at 135° in accordance to the long axis
of the femur. The joint was positioned so that there was
no cranial tibial translocation. A standardized TTA
transparency (Focus®, Indaiatuba, Brazil) was used over
the radiograph to determine the amount of TTA re-
quired to position the patellar tendon perpendicular to
the tibial plateau.
The dogs were positioned in dorsal recumbency and
the affected limb was aseptically prepared. All dogs re-
ceived ceftriaxone (25 mg/kg) preoperative.
A medial parapatellar incision was performed 2 cm
proximally to the tibial plateau and extended distally to
the tibial diaphysis. The periosteum of tibial crest was
reflected cranially to expose the cranial bone margin of
the entire tibial crest. A previously selected TTA bone
plate (Focus®, Indaiatuba, Brazil) was positioned over the
tibial crest and fixed by 2 or 3 locking screws, depending
on the length of the plate. After that, a bicortical osteot-
omy was performed in the tibial crest observing the
plate contour.
The tibial crest, with attached plate, was moved cra-
nially using a spacer and a previously selected cage
(Focus®, Indaiatuba, Brazil), was placed into the oste-
otomy site at the proximal extent of the osteotomy
and secured at its caudal margin to the tibia with a
2.0 mm screw. The cranial cage screw was secured
into the tibial tuberosity and the plate was then se-
cured distally to the tibia with the appropriately sized
screws (2.0 mm; 2.7 mm or 3.5 mm). The surgical
site was then sutured routinely.
Isolation and preparation of MSCs
After the TTA surgery, a subcutaneous fragment of
adipose tissue (approximately 20 g) from the medial
parapatellar region was collected from all animals.
The specimens were stored in 199 medium (M4530,
Sigma Aldrich, São Paulo, Brazil) cooled, and sent to
the Biocell laboratory (Brasília, Brazil), which special-
izes in growth and culture of stem cells. There, the
adipose tissue fragment was submitted to enzymatic
treatment for extraction and expansion of the mesen-
chymal stem cells following a protocol described by
Kang et al. (2012).
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The stem cells were maintained in the culture medium
(37 °C, 5% of CO2) until the eighth postoperative day, and
then about 1.5 million stem cells were removed from the
bottles by trypsinization and transferred with transport
medium to 1.0-mL hypodermic syringes and applied to
the gap formed by the osteotomy. The gap formed by the
osteotomy was localized through palpation, and then the
cells were injected into the gap percutaneously using a
1 ml syringe with a hypodermic needle (30 × 0.8 mm, Bec-
ton Dickinson, São Paulo, Brazil) (Fig. 1).
In the animals of the control group (GC) (n = 5), only
the culture medium was applied without the MSC. In
the animals of the treated group (GT) (n = 4), the culture
medium was treated with MSC. Only the laboratory was
aware of which animals would receive transport with
MSC and which received only the transport medium.
Thus, the study was characterized as double blind, since
neither the surgeon nor the owner knew the compos-
ition of groups.
Qualitative evaluation of radiographic images
On the fifteenth postoperative day, the animals were
evaluated for the clinical condition of the surgical
wound, degree of claudication, effectiveness of the
TTA technique in eliminating the shear movement in
the operated knee, and the level of pain in the oper-
ated area.
The animals were X-rayed (Compact Plus 500 L, Phi-
lips Medical Systems, São Paulo, Brazil) at 15, 30, 60, 90
and 120 days after surgery. Radiographic images were
evaluated by two veterinarians who classified them ac-
cording to Hoffmann et al. (2006). The classification was
made based on the following scores:
 zero - indicates that there was no bone healing;
 I - represents early bone production without
bridging the tibial tuberosity and the axis of the
tibia;
 II - significant bone bridge in one site;
 III - indicates bone bridge in two sites;
 IV - represents bone bridge at all three sites,
including the region of osteotomy proximal to the
cage, the region of osteotomy between the cage and
the plate, and the distal region of the osteotomy to
the plaque (Fig. 2).
Evaluation of the osteogenic potential of MSCs
To assess the osteogenic potential of MSC culture, some
of the cells proliferated in the laboratory were induced to
differentiate into bone tissue. For in vitro osteogenic dif-
ferentiation, the purified MSCs were maintained in a cul-
ture medium containing ascorbic acid (50 μM),
dexamethasone (0.1 μM) and beta-glycerol phosphate
(10 mM) according to the protocol established by Kang et
al. (2012). After cell differentiation, the detection of the
bone matrix was performed by cytochemical staining with
Von Kossa staining (Fig. 2).
Another part of the cells was sent to the MOFA Global
laboratory (Verona, WI, USA) to perform the molecular
characterization through flow cytometry (AMNIS®, Merck,
Darmstadt, Germany) with quantification by image, also
evaluating the degree of purity, functionality and viability
of such cells, through the identification of specific molecu-
lar markers and DNA dyes. For this, 1,000,000 cells were
incubated with specific antibodies, capable of identifying
proteins that are found only in stem cells, called molecular
markers. Such proteins, CD44, CD29, CD90, these pro-
teins are found in the plasma membrane of stem cells with
specific functions.
In addition, to analyze the cell population and to
quantify the degree of functionality, antibodies were
used to identify intracytoplasmic molecular markers,
such as the OCT3/4 and SOX2 proteins, responsible for
the maintenance of the undifferentiated state of the stem
cells. Likewise, cytometry was able to identify the pro-
portion of undifferentiated cells found in the sample.
Analysis of the density of bone trabeculae in the spongy
substance
To evaluate the density of bone trabeculae in the spongy
substance, the radiographic images captured at different
times were processed in an image editing software
(Adobe Photoshop CS6, version 6.0, Adobe Systems Inc.,
San Jose, CA, USA) to delimit the area of interest in
standardized size, according to Mahl et al. (2009).
After the delineation of the cuts representing the
spongy substance in the region of the osteotomy site
after the surgical procedure, the analyzed images of the
groups were processed in Image-Pro Plus 4.1 image
Fig. 1 Use of stem cells. Photograph in craniomedial view
demonstrating percutaneous application of stem cells at the
osteotomy site 8 days after the surgical procedure
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Fig. 2 Photomicrograph of stem cells. Photomicrography demonstrating MSC (a) and osteocytes after Von Kossa staining demonstrating the
calcium (reddish coloration) (b)
Fig. 3 Representative data for the expression of osteocyte mesenchymal stem cell surface markers markers from negative (a, b and c) and
positive (d, e and f) controls using immunoglobulin and specific antibody for CD44, CD29 and CD90. The number of cells analyzed was 1,000,000
for each of the labeled cell types. Purchased from AMNIS employing DiVa software 4.0 and analyzed with Flowjo / Mac version 9.4.7
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analysis software (Media Cybernetics Inc. Silver Springs,
MD) according to Blatt et al. (2004).
Statistical analysis
A descriptive analysis was performed to obtain the
mean and standard deviation, followed by the
Kolmogorov-Smirnov test. The radiographs were di-
vided into groups in the postoperative evaluation pe-
riods so that the images were classified as proposed
by Hoffmann et al. (2006) in different scores and dif-
ferent periods from the application of the Chi-square
test. The density of the bone trabeculae arranged in
the spongy substance was evaluated in each of the pe-
riods for the two groups by applying the Mann-
Whitney test. The density was also compared between
the different periods from the application of Tukey’s
multiple comparison tests between the two groups.
Statistical significance was set at p ≤ 0.05 for all tests,
and the Graph Pad Prism 6.0 program was used.
Results and discussion
In order to ensure that the isolated cells are mesenchy-
mal stem cells, we used the CD44, CD29 and CD90
markers, which were positive, indicating that the sample
consisted of mesenchymal cells (Fig. 3).
Through flow cytometry results, we observed that
97.9% of the cells were OCT3/4 positive and 99.9% of
the cells were SOX2 positive, thereby ensuring that
the cells maintained the undifferentiated state of the
stem cells. In addition, the OCT3/4 and SOX2 tran-
scription factor are involved in the maintenance of
the proliferative state of the stem cells, it being desir-
able that such cells present these factors (Fig. 4).
The radiographs of the groups were divided over
the postoperative evaluation periods (Fig. 5) so that
the images were classified according to the table
below, and the scores were evaluated before the dif-
ferent periods according to the application of the
Chi-square test (Table 1).
Comparing the bone trabeculae density of the newly
formed material after the osteotomy between the differ-
ent groups, it was observed that the GC animals
achieved a mean ossification 36.45% greater after 30 days
compared to the GT (P ≤ 0.033). In the other periods,
there was no statistically significant difference between
the groups (Table 2).
Relatively and partially, and based only on the assess-
ment of claudication, it was observed that the GT ani-
mals had a similar response to GC animals at the end of
the study. Thus, it was possible to extrapolate that the
application of mesenchymal stem cells was not as benefi-
cial as expected with regard to ambulation and reduction
of immediate postoperative discomfort for the treated
group. This study did not agree with Hoffmann et al.
(2006); Lafaver et al. (2007), in which the evaluated ani-
mals had an effective response even in the short term.
In both objective and subjective evaluations, it was ob-
served that the GC obtained results were equal to the GT
in relation to the ossification process at the end of the ex-
periment. However, the GC may have obtained a delay in
the period of differentiation, which can be justified due to
the necessity of reorganization due to the inflammatory
Fig. 4 Expression of cell markers OCT3.4 (a) and SOX2 (b) in mesenchymal stem cells of osteocytes using immunoglobulin and specific antibody.
The number of cells analyzed was 1,000,000 for each of the labeled cell types, Purchased from AMNIS employing DiVa software 4.0 and analyzed
with Flowjo / Mac version 9.4.7
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process after the postoperative introduction of the stem
cells eight days later, unlike the study by Zamprogno
(2007), which found efficacy in therapy with stem cells in-
troduced after 15 days of the first intervention in fractures
and promoted bone union by the end of the study.
As a result, the application of cells should perhaps have
occurred earlier, since the process of cell differentiation
should have started from the moment of their application.
Contrary to this assessment, the cells applied were probably
diverted, in part, due to the reorganization of the inflamma-
tory process present after their introduction into the
medium. Taking into account that the first inflammatory
stage occurs from the first day of injury to the third day
(Cho et al. 2002) and that during this period, the cleaning
of damaged areas and migration of pluripotent cells are
performed, immunosuppressive functions and reduction of
the immune cell response are activated (El-Jawhari et al.
2016), thus justifying the observed response.
In the second phase, called the repair or chondrogenic
phase and characterized by the peak of collagen expres-
sion from the seventh to the fourteenth day (Cho et al.
2002), differentiation of pluripotent cells into osteoblasts
or chondroblasts was observed. This phenomenon was
induced by macrophages, which also regulated the differ-
entiation of pluripotent cells and thus the action of other
immune cells, including T and B lymphocytes located
near the osteoblasts, thus aiding in the differentiation of
cartilage and bone (El-Jawhari et al. 2016).
Bone fracture promotes disruption of blood supply
and subsequent platelet aggregation with the release of
proinflammatory cytokines. These cytokines stimulate
the return of lymphocytes and monocytes/macrophages
to the site of the fracture, initiating the process of bone
healing (El-Jawhari et al. 2016).
The third and final phase, called osteogenic or remod-
eling, begins in the first 24 h after the injury, and the
maximum differentiation occurs between days 14 and 21
after the fracture (Cho et al. 2002). Thus, in the two GT
cases where there was a fracture at 15 days, this may
Fig. 5 Radiographs showing the periods evaluated and the scores. Images a, b, c, d and e represent animals of the GT, respectively, in the
periods of 15, 30, 60, 90 and 120 days. Images f, g, h, i and j represent GC animals, respectively, in the periods of 15, 30, 60, 90 and 120 days.
Score II (a), Score III (b, f and G), Score IV (c, d, e, h, i and j)
Table 1 Classification of ossification (%), according to Hoffman
et al. 2006, of the animals from the control group (GC) and those
treated with mesenchymal stem cells group (GT) throughout the
evaluation period
SCORE Day 15 Day 30 Day 60 Day 90 Day 120 p
GC GT GC GT GC GT GC GT GC GT
ZERO 50 75 20 50 10 – – – – – < 0,0001
I 30 12,5 10 12,5 10 12,5 – – 10 12,5 0,07
II – 12,5 40 25 50 25 30 – 20 – < 0,0001
III 20 – 20 12,5 – 50 30 62,5 30 50 < 0,0001
IV – – 10 – 30 12,5 40 37,5 40 37,5 0,009
The Chi-square test with a significance level of p ≤ 0.05 was performed between
the same periods for the different groups
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have influenced the observed healing delay in relation to
GC animals that presented the fracture late, suggesting
that the introduced stem cells may not have differenti-
ated into osteoblasts, as expected, but again diverted to
the new inflammatory process installed after the fracture
of the tibial tuberosity. In addition, there is the fact that
the timing of the therapeutic intervention in relation to
the inflammatory state is an essential challenge to be ad-
dressed according to El-Jawhari et al. (2016). In any case,
both groups achieved complete ossification within the
postoperative period of 8 to 10 weeks, as proposed by
Hoffmann et al. (2006).
Although there was complete ossification within the es-
timated period, the therapeutic use of MSC for bone loss
recovery did not achieve statistically significant results as
expected in relation to minimizing the estimated gap re-
covery time. The microenvironment of the lesion, and par-
ticularly the local inflammation, interfered with the action
of the stem cells applied in the region of the osteotomy.
Conclusions
The results obtained in this study were not those expected
by the hypothesis we outlined at the beginning, but we
must be careful not to jump to conclusions. This study
used a great variability of ages and dog breeds. Perhaps we
would have obtained a different result if the sample was
more homogeneous, but the sample used in this study rep-
resents the variability that we verified in the clinical rou-
tine. In the future, we intend to carry out new research in
order to overcome these limitations. However, we believe
that we use a very important technique in the routine, so
these results, even if partially inconclusive, should be
shown to delineate research and future uses in the clinic.
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